Current and historical daily PE Ratio for KVUE (
Kenvue Inc
) from 2023 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Kenvue stock (KVUE) PE ratio as of Jun 10 2024 is 23.21.
More Details
Kenvue Inc (KVUE) PE Ratio (TTM) Chart
Kenvue Inc (KVUE) PE Ratio (TTM) Historical Data
View and export this data going back to 2023. Start your Free Trial
Total 277
- 1
- 2
- 3
- 4
| Kenvue PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 23.2 | 2024-04-05 | 26.0 |
| 2024-06-07 | 23.6 | 2024-04-04 | 25.9 |
| 2024-06-06 | 23.9 | 2024-04-03 | 26.1 |
| 2024-06-05 | 24.4 | 2024-04-02 | 26.7 |
| 2024-06-04 | 24.6 | 2024-04-01 | 27.2 |
| 2024-06-03 | 24.7 | 2024-03-28 | 27.5 |
| 2024-05-31 | 24.7 | 2024-03-27 | 24.4 |
| 2024-05-30 | 24.4 | 2024-03-26 | 23.8 |
| 2024-05-29 | 24.2 | 2024-03-25 | 23.5 |
| 2024-05-28 | 24.7 | 2024-03-22 | 23.5 |
| 2024-05-24 | 24.8 | 2024-03-21 | 23.6 |
| 2024-05-23 | 24.9 | 2024-03-20 | 23.3 |
| 2024-05-22 | 25.5 | 2024-03-19 | 23.0 |
| 2024-05-21 | 25.6 | 2024-03-18 | 23.0 |
| 2024-05-20 | 25.5 | 2024-03-15 | 23.2 |
| 2024-05-17 | 26.2 | 2024-03-14 | 22.9 |
| 2024-05-16 | 26.4 | 2024-03-13 | 23.3 |
| 2024-05-15 | 26.3 | 2024-03-12 | 22.9 |
| 2024-05-14 | 26.4 | 2024-03-11 | 22.9 |
| 2024-05-13 | 26.1 | 2024-03-08 | 22.8 |
| 2024-05-10 | 26.3 | 2024-03-07 | 22.6 |
| 2024-05-09 | 26.3 | 2024-03-06 | 22.3 |
| 2024-05-08 | 26.2 | 2024-03-05 | 21.6 |
| 2024-05-07 | 25.7 | 2024-03-04 | 21.6 |
| 2024-05-06 | 24.5 | 2024-03-01 | 21.4 |
| 2024-05-03 | 24.6 | 2024-02-29 | 21.6 |
| 2024-05-02 | 24.5 | 2024-02-28 | 21.8 |
| 2024-05-01 | 24.2 | 2024-02-27 | 21.6 |
| 2024-04-30 | 24.1 | 2024-02-26 | 21.6 |
| 2024-04-29 | 24.4 | 2024-02-23 | 21.9 |
| 2024-04-26 | 24.2 | 2024-02-22 | 21.9 |
| 2024-04-25 | 24.4 | 2024-02-21 | 22.0 |
| 2024-04-24 | 24.5 | 2024-02-20 | 21.7 |
| 2024-04-23 | 24.8 | 2024-02-16 | 21.7 |
| 2024-04-22 | 25.1 | 2024-02-15 | 21.7 |
| 2024-04-19 | 25.1 | 2024-02-14 | 21.7 |
| 2024-04-18 | 25.1 | 2024-02-13 | 21.9 |
| 2024-04-17 | 24.7 | 2024-02-12 | 22.3 |
| 2024-04-16 | 24.5 | 2024-02-09 | 22.0 |
| 2024-04-15 | 24.5 | 2024-02-08 | 22.0 |
| 2024-04-12 | 24.5 | 2024-02-07 | 23.4 |
| 2024-04-11 | 24.9 | 2024-02-06 | 23.5 |
| 2024-04-10 | 25.9 | 2024-02-05 | 23.3 |
| 2024-04-09 | 26.1 | 2024-02-02 | 23.7 |
| 2024-04-08 | 25.7 | 2024-02-01 | 23.8 |
Kenvue Inc (KVUE) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Kenvue Inc
NAICS : 811490
SIC : 2842
ISIN : US49177J1025
Description
Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers